J. Harnett

发表

Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.

David C. Murray, R. Foley, P. Parfrey, 1995, Kidney international.

The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease.

David C. Murray, R. Foley, P. Parfrey, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease.

R. Foley, P. Parfrey, P. Barré, 1996, Journal of the American Society of Nephrology : JASN.

Morbidity and mortality following pelvic ramus fractures in an older Atlantic Canadian cohort

J. Harnett, A. Furey, C. Hamilton, 2019, Canadian journal of surgery. Journal canadien de chirurgie.

Mode of dialysis therapy and mortality in end-stage renal disease.

R. Foley, P. Parfrey, P. Barré, 1998, Journal of the American Society of Nephrology : JASN.

Hypoalbuminemia, Cardiac Morbidity, and Mortality in

R. Foley, P. Parfrey, P. Barré, 1996 .

Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease.

David C. Murray, R. Foley, P. Parfrey, 1996, Kidney international.

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy.

David C. Murray, R. Foley, P. Parfrey, 1995, Kidney international.

Development of a health questionnaire specific for end-stage renal disease.

M. H. Gault, P. Parfrey, J. Harnett, 1989, Nephron.

Effect of an educational intervention on colonoscopy quality outcomes

J. Harnett, B. Evans, M. Ge, 2019, Surgical Endoscopy.

Organ and Metabolic Complications: Cardiac

R. Foley, P. Parfrey, J. Harnett, 1996 .

The prognostic importance of left ventricular geometry in uremic cardiomyopathy.

David C. Murray, R. Foley, P. Parfrey, 1995, Journal of the American Society of Nephrology : JASN.

ERYTHROMYCIN‐CYCLOSPORINE INTERACTION IN RENAL TRANSPLANT RECIPIENTS

M. H. Gault, P. Parfrey, J. Harnett, 1987, Transplantation.

Prosthodontic treatment, patient response, and the need for maintenance of complete implant-supported overdentures: an appraisal of 5 years of prospective study.

J. E. Hutton, R. M. Watson, M. Heath, 1997, The International journal of prosthodontics.

Outcome and risk factors for left ventricular disorders in chronic uraemia.

David C. Murray, R. Foley, P. Parfrey, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Congestive heart failure in dialysis patients.

M. H. Gault, P. Parfrey, P. Barré, 1988, Archives of internal medicine.

Left Ventricular Hypertrophy in Dialysis Patients

R. Foley, P. Parfrey, J. Harnett, 1992 .

Cardiac function and hematocrit level.

R. Foley, P. Parfrey, J. Harnett, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients.

P. Parfrey, P. Barré, J. Harnett, 1990, American journal of nephrology.

Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients.

P. Parfrey, P. Barré, J. Harnett, 1994, Journal of the American Society of Nephrology : JASN.

Cardiac Dysfunction in Chronic Uremia

P. Parfrey, J. Harnett, 2012, Topics in Renal Medicine.

Evaluating the reliability of surgical assessment methods in an orthopedic residency program.

J. Harnett, A. Furey, N. Smith, 2015, Canadian journal of surgery. Journal canadien de chirurgie.

Recurrent hemoperitoneum in women receiving continuous ambulatory peritoneal dialysis.

J. Harnett, H. Gault, D. Gill, 1987, Annals of internal medicine.

Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease.

David C. Murray, R. Foley, P. Parfrey, 2000, Journal of the American Society of Nephrology : JASN.

Hypocalcemia, morbidity, and mortality in end-stage renal disease.

David C. Murray, R. Foley, P. Parfrey, 1996, American journal of nephrology.

IMPACT OF RENAL TRANSPLANTATION ON UREMIC CARDIOMYOPATHY

R. Foley, P. Parfrey, P. Barré, 1995, Transplantation.

HEPATITIS B DISEASE IN DIALYSIS AND TRANSPLANT PATIENTS FURTHER EPIDEMIOLOGIC AND SEROLOGIC STUDIES

P. Parfrey, J. Zeldis, J. Harnett, 1987, Transplantation.

The importance of renal impairment in the natural history of Bardet-Biedl syndrome.

P. Parfrey, J. Harnett, J. Green, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The clinical course of left ventricular hypertrophy in dialysis patients.

P. Parfrey, P. Barré, J. Harnett, 1990, Nephron.

Review: Blood pressurelowering treatments reduce CV morbidity and mortality in patients receiving dialysis

J. Harnett, 2009, Annals of Internal Medicine.

Comparison of Lp(a) concentrations and some potential effects in hemodialysis, CAPD, transplantation, and control groups, and review of the literature.

M. H. Gault, L. Longerich, J. Harnett, 1995, Nephron.

Left ventricular hypertrophy in end-stage renal disease.

M. H. Gault, P. Parfrey, P. Barré, 1988, Nephron.

The feasibility and efficacy of early discharge planning initiated by the admitting department in two acute care hospitals.

P. Parfrey, J. Harnett, H. Vavasour, 1994, Clinical and investigative medicine. Medecine clinique et experimentale.

The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients.

P. Parfrey, J. Harnett, G. Kent, 1993, Nephron.

Long-term evolution of cardiomyopathy in dialysis patients.

David C. Murray, R. Foley, P. Parfrey, 1998, Kidney international.

The spectrum of renal disease in Laurence-Moon-Biedl syndrome.

W. Pryse-Phillips, N. Farid, J. Harnett, 1988, The New England journal of medicine.

Sonographic and urographic correlation in Bardet-Biedl syndrome (Formerly Laurence-Moon-Biedl Syndrome)

W. Pryse-Phillips, N. Farid, J. Harnett, 1988, Urologic radiology.

Low-output left ventricular failure in end-stage renal disease.

M. H. Gault, P. Parfrey, P. Barré, 1987, American journal of nephrology.

Clinical aspects of cardiomyopathy in dialysis patients.

P. Parfrey, J. Harnett, 1994, Blood purification.

Heart failure and ischemic heart disease in chronic uremia.

R. Foley, P. Parfrey, J. Harnett, 1995, Current opinion in nephrology and hypertension.

Comparison of Patients with Idiopathic Calcium Phosphate and Calcium Oxalate Stones

M. H. Gault, P. Parfrey, J. Harnett, 1991, Medicine.

D van Steenberghe, M R Heath, T Jemt, 1995, The International journal of oral & maxillofacial implants.

The long-term outcome of hepatitis B infection in hemodialysis patients.

P. Parfrey, T. Steinman, J. Zeldis, 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome.

W. Pryse-Phillips, P. Parfrey, N. Farid, 1989, The New England journal of medicine.

A 5-year prospective multicenter follow-up report on overdentures supported by osseointegrated implants.

I Herrmann, R M Watson, D van Steenberghe, 1996, The International journal of oral & maxillofacial implants.

Predicting glomerular function from adjusted serum creatinine.

M. H. Gault, L. Longerich, J. Harnett, 1992, Nephron.

Cardiac disease in chronic uremia. Pathophysiology and clinical epidemiology.

P. Parfrey, J. Harnett, 1994, ASAIO journal.

Cardiac disease in uremia.

P. Parfrey, J. Harnett, 1994, Seminars in nephrology.

The natural history of myocardial disease in dialysis patients.

P. Parfrey, P. Barré, J. Harnett, 1991, Journal of the American Society of Nephrology : JASN.

Os calcis fractures: analysis of interobserver variability in using Sanders classification.

J. Harnett, A. Furey, D. Squire, 2003, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

The Management of Congestive Heart Failure in Uremic Patients

P. Parfrey, J. Harnett, 1992 .

Outcome and risk factors of ischemic heart disease in chronic uremia.

David C. Murray, R. Foley, P. Parfrey, 1996, Kidney international.

Long-term cardiac morbidity and mortality during dialysis therapy.

P. Parfrey, J. Harnett, 1994, Advances in nephrology from the Necker Hospital.

What Is the Best Approach to Asymptomatic Coronary Artery Disease in Dialysis Patients Seeking Transplantation?

B. Culleton, J. Harnett, 1995 .